ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.29
-1.75%
US Tech 100
19,770.80
-0.56%
S&P 500
5,782.20
-1.15%
US Dollar vs CAD
1.45275
0.24%
Bitcoin
85,567.96
-0.59%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Eli Lilly and Co (LLY) Share Price

Eli Lilly and Co

Eli Lilly and Co (LLY)

Eli Lilly and Company
Lilly Eli and Co
911.005
-18.72
( -2.01% )
Updated: 11:52:22
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
911.005
Bid
-
Ask
-
Volume
1,751,403
902.7901 Day's Range 929.16
711.4001 52 Week Range 972.53
Market Cap
863.788B
Previous Close
929.72
Open
922.65
Last Trade
1
@
911.7288
Last Trade Time
11:52:22
Financial Volume
US$ 1,609,121,840
VWAP
918.7616
Average Volume (3m)
3,604,749
Shares Outstanding
948,169,999
Dividend Yield
0.66%
PE Ratio
81.55
Earnings Per Share (EPS)
11.17
Revenue
45.04B
Net Profit
10.59B

About Eli Lilly and Co

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.lilly.com
Headquarters
Indianapolis, Indiana, USA
Founded
-
Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker LLY. The last closing price for Eli Lilly was US$929.72. Over the last year, Eli Lilly shares have traded in a share price range of US$ 711.4001 to US$ 972.53.

Eli Lilly currently has 948,169,999 shares outstanding. The market capitalization of Eli Lilly is US$881.53 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 81.55.

Ask ADVFN Intelligence (AI)

Eli Lilly (LLY) Options Flow Summary

LLY Options Flow

Overall Flow

Bullish

Net Premium

25M

Calls / Puts

334.75%

Buys / Sells

103.50%

OTM / ITM

77.39%

Sweeps Ratio

0.82%

LLY Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 hours ago
LLY (-2.01%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
20 hours ago
LLY (-2.01%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
22 hours ago
LLY (-2.01%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
LLY (-2.01%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 25 2025
LLY (-2.01%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
February 25 2025
LLY (-2.01%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
122.0052.47525309336889935.6258893858109914.12903968CS
4102.00512.608776267809935.625805.9353698552876.88548311CS
12100.45512.3934365554810.55935.625725.013604749811.57596413CS
26-39.005-4.1057462553950.01954711.40013540654828.02469176CS
52114.56514.384636633796.44972.53711.40013224489828.62625516CS
156654.795255.569649897256.21972.53255.523087950566.63199582CS
260777.975584.81169661133.03972.53116.553275337400.96981848CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?
The current share price of Eli Lilly is US$ 911.005
How many Eli Lilly shares are in issue?
Eli Lilly has 948,169,999 shares in issue
What is the market cap of Eli Lilly?
The market capitalisation of Eli Lilly is USD 881.53B
What is the 1 year trading range for Eli Lilly share price?
Eli Lilly has traded in the range of US$ 711.4001 to US$ 972.53 during the past year
What is the PE ratio of Eli Lilly?
The price to earnings ratio of Eli Lilly is 81.55
What is the cash to sales ratio of Eli Lilly?
The cash to sales ratio of Eli Lilly is 19.17
What is the reporting currency for Eli Lilly?
Eli Lilly reports financial results in USD
What is the latest annual turnover for Eli Lilly?
The latest annual turnover of Eli Lilly is USD 45.04B
What is the latest annual profit for Eli Lilly?
The latest annual profit of Eli Lilly is USD 10.59B
What is the registered address of Eli Lilly?
The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Eli Lilly website address?
The website address for Eli Lilly is www.lilly.com
Which industry sector does Eli Lilly operate in?
Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OPADOfferpad Solutions Inc
US$ 1.87
(13.33%)
47k
STEMStem Inc
US$ 0.445099
(11.27%)
3.54M
DQDaqo New Energy Corp New
US$ 20.59
(10.58%)
844.53k
CYDChina Yuchai International Ltd
US$ 19.23
(8.89%)
292.69k
GENIGenius Sports Limited
US$ 9.03
(8.53%)
4.93M
PSFEPaysafe Limited
US$ 15.36
(-20.08%)
516.06k
BRCCBRC Inc
US$ 2.095
(-18.48%)
1.75M
BBYBest Buy Company
US$ 74.43
(-14.19%)
8.48M
EBSEmergent Biosolutions Inc
US$ 5.905
(-13.54%)
3.35M
TLYSTillys Inc
US$ 3.47
(-10.80%)
55.46k
FFord Motor Company
US$ 9.185
(-2.18%)
101.65M
LYGLloyds Banking Group Plc
US$ 3.805
(3.40%)
49.32M
NUNu Holdings Ltd
US$ 10.3401
(-1.24%)
49.17M
TAT&T Inc
US$ 26.4899
(-4.44%)
45.5M
BACBank of America Corporation
US$ 42.905
(-5.83%)
41.05M

LLY Discussion

View Posts
BottomBounce BottomBounce 2 months ago
Eli Lilly and Company $LLY Total Debt (mrq) $31.23B Massive debt compared to dwinding cash. Pump and dump
👍️0
peanutz peanutz 2 months ago
Another gloom and doomer . Lilly is fine . I worked there over 10 years and they have a ton in the pipeline . It needs a breather . Crash my a$$
👍️0
MartinLutherKing MartinLutherKing 2 months ago
RNAZ micro rna cancer cure ELAB el-22 obesity target buyout in progress
👍️ 1
MomsSpaghetti MomsSpaghetti 2 months ago
Are you saying small biotech has a chance...? I was thinking the other way...

Eli Lilly has been a major player in CNS disorders, particularly with treatments for depression (e.g., Prozac) and schizophrenia. They are actively exploring new areas in psychiatry, including the potential for psychedelics.

Lilly has shown interest in novel treatments for depression and anxiety and has partnered with companies in the psychedelic space. Their expansion into the psychedelic field could be an opportunity to leverage MindMed's expertise in developing treatments using substances like LSD and MDMA.

I am wondering if they (or others) would might possibly acquire them.
👍️0
fung_derf fung_derf 3 months ago
I've been waiting and waiting for this one to pull back and it has. However, it is fighting mightily to hold support here....Right now I'm thinking it looks moderately hopeful here, but I think $NVO has become the better play now.
👍️0
Saving Grace Saving Grace 4 months ago
Industry changing direction. Big Pharma going south! LLY a major short candidate going into 2025.
👍️0
TechandBio TechandBio 5 months ago
$1000 strikes for Jan 2025 look juicy.

$LLY
👍️0
uksausage uksausage 5 months ago
why?
👍️0
Saving Grace Saving Grace 5 months ago
Big Pharma to crash hard. Be prepared!
👍️0
TechandBio TechandBio 5 months ago
Wonder if Lily Buys SMMT.
$LLY
👍️0
DewDiligence DewDiligence 6 months ago
LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):

https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials… — at a far lower price than its pens, which come with pre-filled doses. These vials will be made available only through LillyDirect, a telehealth platform the company launched in January (https://investor.lilly.com/news-releases/news-release-details/lilly-launches-end-end-digital-healthcare-experience-through ).

…The vials are significantly cheaper than Zepbound pens, which cost just over $1,000 a month without insurance. A month’s supply of the 2.5-milligram dose will cost $399, and a month’s worth of the five-milligram dose will cost $549.

… The company will offer vials with only the two lowest doses of Zepbound. Many patients stay on a five milligram dose… but some gradually increase their dose, up to a maximum of 15 milligrams. Any patient interested in taking more than the five-milligram dose would have to transition to the pens.

…the move could help Lilly regain customers who are currently getting compounded tirzepatide, which typically costs between roughly $250 and $450 a month. Why would anyone want a compounded formulation of tirzepatide derived from Chinese API when they can get the real thing from LLY at close to the same price?
👍️0
Monksdream Monksdream 6 months ago
LLY new 52=week high
👍️0
EnchantedTitan62 EnchantedTitan62 6 months ago
To quote Areosmith ' I'm back in the saddle again' . 💰
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
In the green premarket again. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
Bought back in at open today. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
In regards to new a pharma product.
👍️0
Zardiw Zardiw 7 months ago
$LLY Chart from #DDAmanda - #1 Stock Screener :



Z
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
Added @ $866.29
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
Going to be another green day.
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
I don't think they have sales in Europe yet, that'll change. 💰💰💰
👍️0
EnchantedTitan62 EnchantedTitan62 7 months ago
Uh, probably not .
👍️0
Monksdream Monksdream 8 months ago
LLY new 52=week high
👍️0
EL Sueno EL Sueno 8 months ago
Let's go fans 1000.00!!!
👍️0
Monksdream Monksdream 8 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 8 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 10 months ago
LLY 10Q due 4/30
Next day setttlement begins 5/28
👍️0
north40000 north40000 12 months ago
FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
👍️0
Alfonz66 Alfonz66 12 months ago
Sell now boys you had a great run
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high

👍️0
oldstocks oldstocks 1 year ago
Eli Lilly was investigating Talampanel prior to 2010

For the treatment of epilepsy, malignant gliomas and ALS
development codes LY-300164 , LY300164
results from the trial for ALS have been found negative
Talampanel is not currently under development.
It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
👍️0
ralphey ralphey 1 year ago
I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
👍️0
Monksdream Monksdream 1 year ago
Incredible, isn’t it
What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
Because they are incapable of researching companies
🌈 1 🍆 1
vinsterr vinsterr 1 year ago
800$ tomorrow?
👍️0
Monksdream Monksdream 1 year ago
LLY new 52=week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
🍆 1
lvhd lvhd 1 year ago
Shorted at 625.
👍️0
golfndude golfndude 1 year ago
Great news on their new diabetes drug.
👍️0
peanutz peanutz 1 year ago
Looking for the bottom ,not yet :)
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Amazing financials
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Billionaires dream a while back, speculating
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Interesting company
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Wowwwwwww
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Knew this company from the 80 ssssss
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
lvhd lvhd 1 year ago
Who is pumping?
👍️0

Your Recent History

NYSE
LLY
Eli Lilly
BIT
UC3JRL
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads